| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M605823200 |
| P698 | PubMed publication ID | 17046831 |
| P2093 | author name string | Koichi Sato | |
| Masami Murakami | |||
| Atsushi Kuwabara | |||
| Chihiro Mogi | |||
| Fumikazu Okajima | |||
| Hideaki Tomura | |||
| Akihiro Sekiguchi | |||
| Takao Kimura | |||
| Tamotsu Ishizuka | |||
| Doon-Soon Im | |||
| Mitsuteru Ishiwara | |||
| Alatangaole Damirin | |||
| P433 | issue | 49 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 37457-37467 | |
| P577 | publication date | 2006-10-16 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells | |
| P478 | volume | 281 |
| Q28083058 | AIBP: A Novel Molecule at the Interface of Cholesterol Transport, Angiogenesis, and Atherosclerosis |
| Q34578466 | Aldosterone production in human adrenocortical cells is stimulated by high-density lipoprotein 2 (HDL2) through increased expression of aldosterone synthase (CYP11B2) |
| Q45423411 | An engineered S1P chaperone attenuates hypertension and ischemic injury. |
| Q34440172 | Anti-oxidant properties of high-density lipoprotein and atherosclerosis |
| Q64056930 | ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice |
| Q47152874 | Apolipoprotein C-III in the high-density lipoprotein proteome of cerebral lacunar infarction patients impairs its anti-inflammatory function |
| Q60190673 | Bisphenol-A and Nonylphenol Induce Apoptosis in Reproductive Tract Cancer Cell Lines by the Activation of ADAM17 |
| Q44188060 | Deleterious effect of glycation on the ability of HDL to counteract the inhibitory effect of oxidized LDL on endothelium-dependent vasorelaxation |
| Q36527148 | Dihydrotestosterone regulating apolipoprotein M expression mediates via protein kinase C in HepG2 cells |
| Q38773023 | Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy |
| Q27667968 | Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M |
| Q36312740 | Erythrocyte-derived sphingosine-1-phosphate stabilizes basal hydraulic conductivity and solute permeability in rat microvessels |
| Q39178456 | Extra-virgin olive oil consumption reduces the age-related decrease in HDL and paraoxonase 1 anti-inflammatory activities |
| Q38820716 | Filamin A Expression Negatively Regulates Sphingosine-1-Phosphate-Induced NF-κB Activation in Melanoma Cells by Inhibition of Akt Signaling |
| Q38293467 | HDL and atherothrombotic vascular disease |
| Q37590250 | HDL and cholesterol: life after the divorce? |
| Q33945091 | HDL inhibits the effects of oxidized phospholipids on endothelial cell gene expression via multiple mechanisms |
| Q36765386 | HDL signaling and protection against coronary artery atherosclerosis in mice |
| Q58095621 | HDL-Mediated Lipid Influx to Endothelial Cells Contributes to Regulating Intercellular Adhesion Molecule (ICAM)-1 Expression and eNOS Phosphorylation |
| Q26779667 | HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applications |
| Q36623447 | HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation |
| Q26782972 | HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis |
| Q34053101 | HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate |
| Q35238369 | High density lipoprotein stimulated migration of macrophages depends on the scavenger receptor class B, type I, PDZK1 and Akt1 and is blocked by sphingosine 1 phosphate receptor antagonists |
| Q37305341 | High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease |
| Q33727619 | High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate |
| Q52663632 | High-density lipoprotein protects cardiomyocytes against necrosis induced by oxygen and glucose deprivation through SR-B1, PI3K, and AKT1 and 2. |
| Q34714464 | High-density lipoprotein: a novel target for antirestenosis therapy |
| Q26774792 | Importance of Apolipoprotein A-I in Multiple Sclerosis |
| Q27664175 | In Vitro and in Vivo Analysis of the Binding of the C Terminus of the HDL Receptor Scavenger Receptor Class B, Type I (SR-BI), to the PDZ1 Domain of Its Adaptor Protein PDZK1 |
| Q36708971 | Influence of PDZK1 on lipoprotein metabolism and atherosclerosis |
| Q34497101 | Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury |
| Q33642067 | Involvement of 4E-BP1 in the protection induced by HDLs on pancreatic beta-cells |
| Q42114304 | LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate |
| Q36680439 | Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer |
| Q36520311 | Macrophage SR-BI regulates LPS-induced pro-inflammatory signaling in mice and isolated macrophages |
| Q33717436 | Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells |
| Q42705131 | Modulators of Protein Kinase C Affect SR-BI-Dependent HDL Lipid Uptake in Transfected HepG2 Cells |
| Q37314961 | New roles of HDL in inflammation and hematopoiesis |
| Q36406480 | Novel biological functions of high-density lipoprotein cholesterol |
| Q35130512 | Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system |
| Q37899798 | Progress in HDL-based therapies for atherosclerosis |
| Q37076473 | Regulation of signal transduction by HDL. |
| Q38829760 | Resveratrol exerts a biphasic effect on apolipoprotein M. |
| Q37871354 | Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein |
| Q33767978 | Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI |
| Q39157833 | S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization. |
| Q28074790 | SR-BI: Linking Cholesterol and Lipoprotein Metabolism with Breast and Prostate Cancer |
| Q38293447 | Signal transduction by HDL: agonists, receptors, and signaling cascades |
| Q45947801 | Signaling pathways involved in DNA synthesis and migration in response to lysophosphatidic acid and low-density lipoprotein in coronary artery smooth muscle cells. |
| Q42874647 | Sphingolipids: The Oil on the TRAFire That Promotes Inflammation |
| Q38654911 | Sphingosine 1-Phosphate and Atherosclerosis. |
| Q37909176 | Sphingosine 1-phosphate in coagulation and inflammation. |
| Q33405952 | Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration |
| Q47303580 | Sphingosine-1-Phosphate Receptor 1, Expressed in Myeloid Cells, Slows Diet-Induced Atherosclerosis and Protects against Macrophage Apoptosis in Ldlr KO Mice. |
| Q38817761 | Sphingosine-1-Phosphate Signaling in Endothelial Disorders |
| Q92405275 | Sphingosine-1-Phosphate and Macrophage Biology-How the Sphinx Tames the Big Eater |
| Q83387910 | Sphingosine-1-phosphate attenuates lung injury induced by intestinal ischemia/reperfusion in mice: role of inducible nitric-oxide synthase |
| Q24336131 | Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2 |
| Q39618723 | Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectin |
| Q44926429 | Stimulation of phagocyte adhesion to endothelial cells by modified VLDL and HDL requires scavenger receptor BI. |
| Q63684350 | The effect of chronic kidney disease on lipid metabolism |
| Q37978209 | The emerging role of HDL in glucose metabolism |
| Q38760636 | The pleiotropic vasoprotective functions of high density lipoproteins (HDL). |
| Q26862336 | The role of sphingosine-1-phosphate in endothelial barrier function |
| Q33880223 | Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient |
| Q40287159 | Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression. |
Search more.